Bringing genetic tests into the clinic

Hospital Practice

Volumn 33, Issue 1, 1998, Pages 107-128

  Holtzman, Neil A ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; CHROMOSOME 13; CHROMOSOME 17; DIAGNOSTIC ACCURACY; GENE MUTATION; GENETIC SCREENING; HUMAN; ONCOGENE; RACE DIFFERENCE; REVIEW; SAFETY;

EID: 0031931042     PISSN: 87502836     EISSN: None     Source Type: Journal    
DOI: 10.1080/21548331.1998.11443623     Document Type: Review

References (13)

1. Andrews LB, Fullarton JE, Holtzman NA, Motulsky AG (Eds). National Academy Press, Washington, D.C., 1994
2. Geller G et al: Incorporation of genetics in primary care practice: Will physicians do the counseling and will they be directive? Arch Fam Med 2:1119, 1993
3. Geller G, Holtzman NA: A qualitative assessment of primary care physicians' perceptions about the ethical and social implications of offeringgenetic testing. Qualitative Health Research 5:97, 1995
4. Hayes A et al: The effect of mendelian disease on human health. II: Response to treatment. Am J Med Genet 21:243, 1985
5. Hofman KJ et al: Physicians' knowledge of genetics and genetic tests. Acad Med 68:625, 1993
6. Holtzman NA: The interpretation of laboratory results: The paradoxical effect of medical training. J Clin Ethics 2:241, 1991
7. Holtzman NA: Are we ready to screen for inherited susceptibility to cancer? Oncology 10:57, 1996
8. Holtzman NA et al: Predictive genetic testing: From basic research to clinical practice. Science 278:602, 1997
9. Promoting Safe and Effective Genetic Testing in the United States: Final Report of the Task Force on Genetic Testing. Holtzman NA, Watson MS (Eds). National Human Genome Research Institute, September 1997. http://www.nhgri.nih.gov/ELSI/TFGT_final/
10. Struewing JP et al: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New Engl J Med 336:1401, 1997
11. Tambor ES et al: Offering cystic fibrosis carrier screening to an HMO population: Factors associated with utilization. Am J Hum Genet 55:626, 1994
12. Treacy E, Childs B, Scriver CR: Response to treatment in hereditary metabolic disease: 1993 survey and 10-year comparison. Am J Hum Genet 56:359, 1995
13. Wexler NS: The Tiresias complex: Huntington's disease as a paradigm of testing for late-onset disorders. FASEB J 6:2820, 1992